These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31882184)

  • 1. 244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10-12, 2019, Hoofdorp, The Netherlands.
    Dangouloff T; Burghes A; Tizzano EF; Servais L;
    Neuromuscul Disord; 2020 Jan; 30(1):93-103. PubMed ID: 31882184
    [No Abstract]   [Full Text] [Related]  

  • 2. 190 th ENMC international workshop: Spinal muscular atrophy with respiratory distress/distal spinal muscular atrophy type 1: 11-13 May 2012, Naarden, The Netherlands.
    van der Pol WL; Talim B; Pitt M; von Au K
    Neuromuscul Disord; 2013 Jul; 23(7):602-9. PubMed ID: 23726377
    [No Abstract]   [Full Text] [Related]  

  • 3. 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands.
    Bertini E; Burghes A; Bushby K; Estournet-Mathiaud B; Finkel RS; Hughes RA; Iannaccone ST; Melki J; Mercuri E; Muntoni F; Voit T; Reitter B; Swoboda KJ; Tiziano D; Tizzano E; Topaloglu H; Wirth B; Zerres K
    Neuromuscul Disord; 2005 Nov; 15(11):802-16. PubMed ID: 16202598
    [No Abstract]   [Full Text] [Related]  

  • 4. 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands.
    Finkel R; Bertini E; Muntoni F; Mercuri E;
    Neuromuscul Disord; 2015 Jul; 25(7):593-602. PubMed ID: 26045156
    [No Abstract]   [Full Text] [Related]  

  • 5. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 218th ENMC International Workshop:: Revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19-21 February 2016.
    Finkel RS; Sejersen T; Mercuri E;
    Neuromuscul Disord; 2017 Jun; 27(6):596-605. PubMed ID: 28392274
    [No Abstract]   [Full Text] [Related]  

  • 8. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 9. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands.
    Zerres K; Davies KE
    Neuromuscul Disord; 1999 Jun; 9(4):272-8. PubMed ID: 10399757
    [No Abstract]   [Full Text] [Related]  

  • 10. 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.
    Ellis JA; Vroom E; Muntoni F
    Neuromuscul Disord; 2013 Aug; 23(8):682-9. PubMed ID: 23791627
    [No Abstract]   [Full Text] [Related]  

  • 11. Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy.
    Motyl AAL; Gillingwater TH
    Cell Rep Med; 2022 Aug; 3(8):100725. PubMed ID: 35977471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for spinal muscular atrophy: an impetus for newborn screening.
    EBioMedicine; 2021 Jul; 69():103507. PubMed ID: 34315607
    [No Abstract]   [Full Text] [Related]  

  • 13. Newborn infant screening for spinal muscular atrophy: Chances and challenges.
    Mueller-Felber W
    Dev Med Child Neurol; 2022 May; 64(5):535. PubMed ID: 35156200
    [No Abstract]   [Full Text] [Related]  

  • 14. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 15. Universal newborn screening for spinal muscular atrophy in Ukraine.
    Olkhovych N; Gorovenko N; Servais L
    Lancet; 2023 Jul; 402(10398):288-289. PubMed ID: 37481267
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal Newborn Screening for Spinal Muscular Atrophy.
    Oskoui M; Dangouloff T; Servais L
    JAMA Pediatr; 2024 Jun; 178(6):520-521. PubMed ID: 38587838
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
    Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C
    Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland.
    Gillingwater TH; McWilliam C; Horrocks I; McWilliam K; Hamilton M; Fletcher E; Williams N; Smith S; Parson SH
    Scott Med J; 2022 Feb; 67(1):46-47. PubMed ID: 35147460
    [No Abstract]   [Full Text] [Related]  

  • 19. Newborn screening urged for fatal neurological disorder.
    Wadman M
    Science; 2018 Jun; 360(6396):1385. PubMed ID: 29954959
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of newborn screening for spinal muscular atrophy.
    Landfeldt E
    Dev Med Child Neurol; 2023 Jan; 65(1):8-9. PubMed ID: 35698880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.